Multiple Sclerosis (MS).
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Clinically definite MS Age > 20 and <65 years Disability between 4.5 and 6.5 on the Expanded Disability Status Scale (EDSS) Walking ability according to the EDSS score A minimal leg spasticity score = 1 on the Modified Ashworth spasticity scale
Exclusion criteria
Exclusion criteria: Pregnant women Neurological, orthopedic and severe cardiac comorbidities Peripheral vestibular disorders (i.e., positional paroxysmal vertigo, Meniere’s disease, and acoustic neuroma) Blindness in one or both eyes Exacerbation in the past 2 months Exacerbation during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The stability indices at both static and dynamic levels of the Biodex Balance System. Timepoint: Before and after the intervention. Method of measurement: The Biodex Balance System (302-950 model, Biodex Medical Systems, Inc., New York, USA). | — |
Secondary
| Measure | Time frame |
|---|---|
| The Berg Balance Scale Score. Timepoint: Before and after the intervention. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences